Literature DB >> 21562041

Differential effects of HIV viral load and CD4 count on proliferation of naive and memory CD4 and CD8 T lymphocytes.

Sharat Srinivasula1, Richard A Lempicki, Joseph W Adelsberger, Chiung-Yu Huang, Joshua Roark, Philip I Lee, Adam Rupert, Randy Stevens, Irini Sereti, H Clifford Lane, Michele Di Mascio, Joseph A Kovacs.   

Abstract

We previously showed that HIV infection leads to expansion of a rapidly proliferating pool (s(1)) of CD4 and CD8 T lymphocytes. In the current study, we used in vivo labeling with bromodeoxyuridine to characterize the kinetics of naive, memory, and activated (HLA-DR(+)/CD38(+)) subpopulations of CD4 and CD8 T lymphocytes, and to examine the relationship between kinetic parameters and baseline CD4 counts, HIV viral load, potential markers of microbial translocation, and cytokine levels. Activated cells showed the highest proliferation rates, followed by effector and central memory cells, with naive cells showing the lowest rates, for both CD4 and CD8 T cells. HIV viral load correlated with s(1) of CD4 and CD8 effector memory cells, as well as CD8 naive cells, whereas CD4 cell counts correlated inversely with naive CD4 s(1). Endotoxin levels showed a weak negative association with CD4 but not CD8 s(1). INF-γ and TNF-α were associated with s(1) for CD4 and CD8 cells, respectively. Thus, HIV is the primary driving force behind the activation and proliferation of most subsets of both CD4 and CD8 T lymphocytes, whereas naive CD4 cell proliferation likely represents a homeostatic response. Microbial translocation does not appear to play an important role in this proliferation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21562041      PMCID: PMC3138680          DOI: 10.1182/blood-2011-02-335174

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

1.  Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy.

Authors:  H Mohri; A S Perelson; K Tung; R M Ribeiro; B Ramratnam; M Markowitz; R Kost; A Hurley; L Weinberger; D Cesar; M K Hellerstein; D D Ho
Journal:  J Exp Med       Date:  2001-11-05       Impact factor: 14.307

2.  Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients.

Authors:  R A Lempicki; J A Kovacs; M W Baseler; J W Adelsberger; R L Dewar; V Natarajan; M C Bosche; J A Metcalf; R A Stevens; L A Lambert; W G Alvord; M A Polis; R T Davey; D S Dimitrov; H C Lane
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

3.  Measurement and modeling of human T cell kinetics.

Authors:  Derek C Macallan; Becca Asquith; Andrew J Irvine; Diana L Wallace; Andrew Worth; Hala Ghattas; Yan Zhang; George E Griffin; David F Tough; Peter C Beverley
Journal:  Eur J Immunol       Date:  2003-08       Impact factor: 5.532

4.  CD4+Ki67+ lymphocytes in HIV-infected patients are effector T cells accumulated in the G1 phase of the cell cycle.

Authors:  B Combadère; C Blanc; T Li; G Carcelain; C Delaugerre; V Calvez; R Tubiana; P Debré; C Katlama; B Autran
Journal:  Eur J Immunol       Date:  2000-12       Impact factor: 5.532

5.  Turnover rates of B cells, T cells, and NK cells in simian immunodeficiency virus-infected and uninfected rhesus macaques.

Authors:  Rob J De Boer; Hiroshi Mohri; David D Ho; Alan S Perelson
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

6.  Rapid turnover of effector-memory CD4(+) T cells in healthy humans.

Authors:  Derek C Macallan; Diana Wallace; Yan Zhang; Catherine De Lara; Andrew T Worth; Hala Ghattas; George E Griffin; Peter C L Beverley; David F Tough
Journal:  J Exp Med       Date:  2004-07-12       Impact factor: 14.307

7.  Persistent immune activation in HIV-1 infection is associated with progression to AIDS.

Authors:  Mette D Hazenberg; Sigrid A Otto; Birgit H B van Benthem; Marijke Th L Roos; Roel A Coutinho; Joep M A Lange; Dörte Hamann; Maria Prins; Frank Miedema
Journal:  AIDS       Date:  2003-09-05       Impact factor: 4.177

8.  IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation.

Authors:  Irini Sereti; Kara B Anthony; Hector Martinez-Wilson; Richard Lempicki; Joseph Adelsberger; Julia A Metcalf; Claire W Hallahan; Dean Follmann; Richard T Davey; Joseph A Kovacs; H Clifford Lane
Journal:  Blood       Date:  2004-04-13       Impact factor: 22.113

9.  CD14 is an acute-phase protein.

Authors:  Sylvette Bas; Benoit R Gauthier; Ursula Spenato; Sybille Stingelin; Cem Gabay
Journal:  J Immunol       Date:  2004-04-01       Impact factor: 5.422

10.  Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.

Authors:  J A Kovacs; R A Lempicki; I A Sidorov; J W Adelsberger; B Herpin; J A Metcalf; I Sereti; M A Polis; R T Davey; J Tavel; J Falloon; R Stevens; L Lambert; R Dewar; D J Schwartzentruber; M R Anver; M W Baseler; H Masur; D S Dimitrov; H C Lane
Journal:  J Exp Med       Date:  2001-12-17       Impact factor: 14.307

View more
  16 in total

Review 1.  The role of cytokines in the pathogenesis and treatment of HIV infection.

Authors:  Marta Catalfamo; Cecile Le Saout; H Clifford Lane
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-26       Impact factor: 7.638

2.  An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy.

Authors:  John R Koethe; Cathy A Jenkins; Bryan E Shepherd; Samuel E Stinnette; Timothy R Sterling
Journal:  Clin Infect Dis       Date:  2011-09-26       Impact factor: 9.079

Review 3.  The end of AIDS: HIV infection as a chronic disease.

Authors:  Steven G Deeks; Sharon R Lewin; Diane V Havlir
Journal:  Lancet       Date:  2013-10-23       Impact factor: 79.321

4.  Antiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir size.

Authors:  Vivek Jain; Wendy Hartogensis; Peter Bacchetti; Peter W Hunt; Hiroyu Hatano; Elizabeth Sinclair; Lorrie Epling; Tzong-Hae Lee; Michael P Busch; Joseph M McCune; Christopher D Pilcher; Frederick M Hecht; Steven G Deeks
Journal:  J Infect Dis       Date:  2013-07-12       Impact factor: 5.226

Review 5.  Antigen-dependent and -independent mechanisms of T and B cell hyperactivation during chronic HIV-1 infection.

Authors:  Anna Haas; Kathrin Zimmermann; Annette Oxenius
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

6.  A mechanistic model for bromodeoxyuridine dilution naturally explains labelling data of self-renewing T cell populations.

Authors:  Vitaly V Ganusov; Rob J De Boer
Journal:  J R Soc Interface       Date:  2012-11-08       Impact factor: 4.118

7.  Quantifying T lymphocyte turnover.

Authors:  Rob J De Boer; Alan S Perelson
Journal:  J Theor Biol       Date:  2013-01-09       Impact factor: 2.691

Review 8.  Immune activation and HIV persistence: implications for curative approaches to HIV infection.

Authors:  Nichole R Klatt; Nicolas Chomont; Daniel C Douek; Steven G Deeks
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

9.  Early Initiation Rather Than Prolonged Duration of Antiretroviral Therapy in HIV Infection Contributes to the Normalization of CD8 T-Cell Counts.

Authors:  Wei Cao; Vikram Mehraj; Benoit Trottier; Jean-Guy Baril; Roger Leblanc; Bertrand Lebouche; Joseph Cox; Cecile Tremblay; Wei Lu; Joel Singer; Taisheng Li; Jean-Pierre Routy; S Vézina; L Charest; M Milne; E Huchet; S Lavoie; J Friedman; M Duchastel; F Villielm; P Côté; M Potter; B Lessard; M A Charron; S Dufresne; M E Turgeon; D Rouleau; L Labrecque; C Fortin; A de Pokomandy; V Hal-Gagné; M Munoz; B Deligne; V Martel-Laferrière; N Gilmore; M Fletcher; J Szabo
Journal:  Clin Infect Dis       Date:  2015-09-08       Impact factor: 9.079

10.  Naïve CD4+ cell counts significantly decay and high HIV RNA levels contribute to immunological progression in long-term non-progressors infected with HIV by blood products: a cohort study.

Authors:  Ling Xu; Yubin Liu; Xiaojing Song; Yanling Li; Yang Han; Ting Zhu; Wei Cao; Taisheng Li
Journal:  BMC Immunol       Date:  2021-06-03       Impact factor: 3.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.